Evidence map›Paper›PMID 38888968›Full record

ArticleThe Journal of clinical investigation2024

Dysfunction of infiltrating cytotoxic CD8+ T cells within the graft promotes murine kidney allotransplant tolerance.

Takahiro Yokose, Edward S Szuter, Ivy Rosales, Michael T Guinn, Andrew S Liss, Taisuke Baba, David A Ruddy, Michelle Piquet, Jamil Azzi, A Benedict Cosimi and 4 more

Abstract read
In one paragraph

Article in The Journal of clinical investigation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. T-Cell Remodeling in Renal Fibrosis: From Acute Injury to Chronic Kidney Disease.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  3. Article
  4. Article
  5. CD8Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Can mouse kidney transplant models inform mechanisms of injury and acceptance in clinical kidney transplantation?American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2025
    Review
  12. Article
  13. Article
  14. What makes the kidney so tolerant?The Journal of clinical investigation · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Takahiro YokoseCenter for Transplantation Sciences, Department of Surgery and.
Edward S SzuterCenter for Transplantation Sciences, Department of Surgery and.
Ivy RosalesCenter for Transplantation Sciences, Department of Surgery and.
Michael T GuinnCenter for Transplantation Sciences, Department of Surgery and.
Andrew S LissDepartment of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Taisuke BabaDepartment of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
David A RuddyNovartis Biomedical Research, Oncology, Cambridge, Massachusetts, USA.
Michelle PiquetNovartis Biomedical Research, Oncology, Cambridge, Massachusetts, USA.
Jamil AzziTransplantation Research Center, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
A Benedict CosimiCenter for Transplantation Sciences, Department of Surgery and.
Paul S RussellCenter for Transplantation Sciences, Department of Surgery and.
Joren C MadsenCenter for Transplantation Sciences, Department of Surgery and.
Robert B ColvinCenter for Transplantation Sciences, Department of Surgery and.
Alessandro AlessandriniCenter for Transplantation Sciences, Department of Surgery and.

Funding

Project 3: Enhanced Costimulation Blockade to Achieve Clinically Relevant Heart Allograft ToleranceP01HL158504 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI PIERSON, RICHARD N · 2021 to 2025
$12.1M
Project 3: The Role of Erythropoietin in Kidney Transplant ToleranceP01AI123086 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI MADSEN, JOREN C · 2016 to 2020
$10.6M
NHLBI NIH HHS P01 HL158504NIAID NIH HHS P01 AI123086
6 · The paper itself

Abstract

Tolerance of mouse kidney allografts arises in grafts that develop regulatory tertiary lymphoid organs (rTLOs). Single-cell RNA-seq (scRNA-seq) data and adoptive transfer of alloreactive T cells after transplantation showed that cytotoxic CD8+ T cells are reprogrammed within the accepted graft to an exhausted/regulatory-like phenotype mediated by IFN-γ. Establishment of rTLOs was required because adoptive transfer of alloreactive T cells prior to transplantation results in kidney allograft rejection. Despite the presence of intragraft CD8+ cells with a regulatory phenotype, they were not essential for the induction and maintenance of kidney allograft tolerance since renal allotransplantation into CD8-KO recipients resulted in acceptance and not rejection. Analysis of scRNA-seq data from allograft kidneys and malignant tumors identified similar regulatory-like cell types within the T cell clusters and trajectory analysis showed that cytotoxic CD8+ T cells are reprogrammed into an exhausted/regulatory-like phenotype intratumorally. Induction of cytotoxic CD8+ T cell dysfunction of infiltrating cells appears to be a beneficial mechanistic pathway that protects the kidney allotransplant from rejection through a process we call "defensive tolerance." This pathway has implications for our understanding of allotransplant tolerance and tumor resistance to host immunity.

Indexed as

Kidney TransplantationTransplantation ToleranceAllograftsAnimalsCD8-Positive T-LymphocytesGraft RejectionInterferon-gammaMiceMice, KnockoutT-Lymphocytes, CytotoxicInterferon-gammaImmunologyOrgan transplantationT cellsToleranceTransplantation

Identifiers

PMID38888968
PMCPMC11324304

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.